These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3081055)

  • 21. Cholinergic-dopaminergic interactions and the mechanisms of action of antidepressants.
    Martin-Iverson MT; Leclere JF; Fibiger HC
    Eur J Pharmacol; 1983 Oct; 94(3-4):193-201. PubMed ID: 6418553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of limbic versus striatal dopamine loss on motoric function.
    Carey RJ
    Behav Brain Res; 1983 Mar; 7(3):283-96. PubMed ID: 6404287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin effects on brain dopaminergic systems.
    Haubrich DR; Martin GE; Pflueger AB; Williams M
    Brain Res; 1982 Jan; 231(1):216-21. PubMed ID: 7198926
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.
    Bardo MT; Bowling SL; Pierce RC
    Psychopharmacology (Berl); 1990; 101(3):338-43. PubMed ID: 2163539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential involvement of dopamine-containing tracts in 5-hydroxytryptamine-dependent behaviours caused by amphetamine in large doses.
    Andrews CD; Fernando JC; Curzon G
    Neuropharmacology; 1982 Jan; 21(1):63-8. PubMed ID: 6801538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
    Broderick PA; Gardner EL; van Praag HM
    Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic antagonists attenuate neurotensin-stimulated accumbens and striatal dopamine metabolism.
    Rivest R; Marsden CA
    Neuroscience; 1992; 47(2):341-9. PubMed ID: 1641127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
    Meloni R; Gale K
    Prog Brain Res; 1990; 82():467-71. PubMed ID: 2127112
    [No Abstract]   [Full Text] [Related]  

  • 30. Unilateral 6-hydroxydopamine lesions of dopamine neurons produce bilateral self-stimulation deficits.
    Carey RJ
    Behav Brain Res; 1982 Oct; 6(2):101-14. PubMed ID: 6814462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors.
    Helmeste DM; Seeman P
    Psychiatry Res; 1982 Dec; 7(3):351-9. PubMed ID: 6962442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic effects of nicotine on mesolimbic dopaminergic system in rats.
    Fung YK; Lau YS
    Pharmacol Biochem Behav; 1992 Jan; 41(1):57-63. PubMed ID: 1347177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine in the mesolimbic system of the rat brain: endogenous levels and the effects of drugs on the uptake mechanism and stimulation of adenylate cyclase activity.
    Horn AS; Cuello AC; Miller RJ
    J Neurochem; 1974 Feb; 22(2):265-70. PubMed ID: 4829953
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat.
    Kalivas PW; Burgess SK; Nemeroff CB; Prange AJ
    Neuroscience; 1983 Mar; 8(3):495-505. PubMed ID: 6406930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior.
    Kelley AE; Gauthier AM; Lang CG
    Behav Brain Res; 1989 Oct; 35(1):27-39. PubMed ID: 2803542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic inhibition of 6,7-ADTN-induced hyperactivity after injection into the nucleus accumbens. Specificity and comparison with other models.
    Arnt J
    Eur J Pharmacol; 1983 May; 90(1):47-55. PubMed ID: 6135618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.